Sun Pharmaceutical Industries, Inc.
Clinical trials sponsored by Sun Pharmaceutical Industries, Inc., explained in plain language.
-
New Light-Activated gel aims to clear precancerous skin spots
Disease control Recruiting nowThis study tests a reformulated gel (Levulan Kerastick) combined with blue light therapy to treat actinic keratosis, a common precancerous skin condition. About 160 adults with 4 to 8 mild-to-moderate spots on the face or bald scalp will receive either the active gel or a placebo…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New light therapy could zap precancerous arm spots
Disease control Recruiting nowThis study tests a reformulated cream (Levulan Kerastick) plus blue light therapy for actinic keratosis, a common precancerous skin condition. About 260 adults with 4-8 spots on one arm will receive either the active treatment or a placebo cream, followed by light exposure. The m…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill may help teens regrow hair lost to alopecia
Disease control Recruiting nowThis study tests an oral drug called deuruxolitinib in teenagers aged 12 to 17 who have lost at least half their scalp hair due to alopecia areata. The goal is to see if the drug can safely regrow hair. Participants will be randomly assigned to receive either the drug or a placeb…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC